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dii,1 is a life-threatening complication after hematopoietic
stem cell transplantation (HSCT). Cutaneous toxoplasmosis
(CT) is very rare, mainly affecting severely immunocom-
promised patients.2 We report a case presenting with subtle
maculopapular lesions as the first manifestation of
toxoplasmosis.
A 15-year-old boy with a 4-year history of myelodys-
plastic syndrome was admitted for allogenic peripheral
blood stem cell transplantation due to refractory pancyto-
penia. After transplantation, he developed Grade IV graft
versus host disease (GVHD), which improved after immu-
nosuppressive therapy. However, scattered erythematous
maculopapules were noticed on the trunk and extremities
(Figures 1A and 1B) on Day 66, followed by spiking fever 2
days later. Antibiotics, including voriconazole, were initi-
ated. A skin biopsy was performed (Figure 1A) on Day 73,
which revealed intracytoplasmic cysts packed with
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consistent with CT.
The patient developed lethargy, conscious disturbance,
and visual hallucination on Day 80. Brain magnetic reso-
nance imaging revealed numerous parenchyma nodules,
suggestive of an infection. The diagnosis of toxoplasmosis
was supported by positive results of polymerase chain re-
action (PCR) in the cerebrospinal fluid and bone marrow
aspiration. Oral pyrimethamine 2 mg/kg/d and intravenous
clindamycin 600 mg q6h were initiated on Day 87. The pa-
tient regained consciousness a few days later. However, he
developed pneumonia. Acid-fast bacilli were demonstrated
in the sputum, and Mycobacterium hemophilum, Eps-
teineBar virus, and T. gondii were detected by PCR in the
bronchoalveolar lavage specimen. He died of multiple
organ failure on Day 112.
CT is very rare; only 12 cases have been reported in the
past 3 decades,2 including five cases with HSCT, three with
human immunodeficiency virus infection, and two immu-
nocompetent patients. Our patient represents the second
case in which CT was the first manifestation of toxoplas-
mosis. The first reported case of CT also was a young child
after HSCT.2 Cutaneous manifestations of CT were usually
subtle, mostly showing erythematous or purpuric mac-
ulopapular lesions in which drug eruption, cutaneous
GVHD, or viral infection was considered clinically impor-
tant in most cases. Eight patients (5 with HSCT) wereby Elsevier Taiwan LLC. This is an open access article under the
4.0/).
Figure 1 Discrete, small erythematous maculopapules on the (A) thigh and (B) chest. (C) A skin biopsy specimen from a lesion on
the thigh reveals an intracytoplasmic cyst in a keratinocyte filled with tiny bradyzoites (HE 400). HE Z hematoxylin and eosin.
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clindamycin, and three recovered (1 with HSCT). The
overall outcomes of these patients were poor; eight pa-
tients (62%) were in fatal condition, including five of the
six HSCT recipients.
The histopathology of CT was subtle, usually with little
inflammation, mimicking drug eruption and cutaneous
GVHD.3 Intracellular zoites were found in 10 cases, mostly
with bradyzoites in cysts in the epidermis. Occasionally,
tachyzoites were observed in keratinocytes or in the
dermis, either in histiocytes or extracellularly. These zoites
need to be distinguished morphologically from other tiny
organisms, including Histoplasmosis capsulatum, Leish-
mania, and Trypanosoma, and can be confirmed immuno-
histochemically using antitoxoplasma antibody in paraffin
sections (positive in 65%), and PCR study (positive in
75%).4,5
Diagnosis of CT is challenging because the skin lesions
are usually subtle and are easily overlooked or confused
with other more common post-HSCT eruptions. The recog-
nition of these tiny intracellular protozoa requires a highindex of suspicion. It is important to include CT in the dif-
ferential diagnosis of post-HSCT skin eruptions.References
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